Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pediatric Oncology
•
Rheumatology
•
Anemia
•
Hematology
•
Pediatric Hematology
•
Systemic lupus erythematosus
What is your approach to treatment of warm hemolytic anemia in patients with lupus who have not responded to rituximab and/or cyclophosphamide?
Is there utility for PLEX in these patients?
Related Questions
What is your approach to further work-up and management of neutropenia in patients with SLE/RA overlap?
When would you consider using G-CSF in patients with rheumatic disease who have received cyclophosphamide?
In the setting of secondary HLH associated with initial diagnosis of lymphoma, would you adjust steroid dose and type to account for differences in HLH and lymphoma treatment protocols?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
How do you approach dosing of anakinra in MAS?
How do you approach diagnosis and treatment of HLH/MAS following CAR T-cell therapy?
What is your approach to treatment of infection-triggered HLH that does not respond to treatment of the underlying infection?
Does your evaluation of a young person with spontaneous upper extremity DVT vary as compared to lower extremity DVT?
What is your practice regarding giving G-CSF to patients with ALL during initial induction?
How would you manage a case of subcutaneous panniculitis-like T cell lymphoma (A/B) who is already on steroids and methotrexate for autoimmune disease?